therapeutic action: Antifungal drug efficacy

Acidic pH Reduces Fluconazole Susceptibility in Cryptococcus neoformans by Altering Iron Uptake and Enhancing Ergosterol Biosynthesis

This research shows that acidic environments, like those found in inflamed tissues and inside immune cells, make the fungus Cryptococcus neoformans more resistant to the antifungal drug fluconazole. The fungus adapts to acidic conditions by using an alternative iron uptake system that increases the production of protective compounds (ergosterol) in its cell membrane. Understanding this pH-dependent resistance mechanism could help develop better treatment strategies for cryptococcal infections in patients with compromised immune systems.

Read More »

Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

Fungal infections are becoming harder to treat as fungi develop resistance to antifungal drugs. This review explains how scientists can use experimental evolution—growing fungi in controlled laboratory conditions while exposing them to drugs—to understand how and why resistance develops. By studying these evolutionary processes and using mathematical models to predict outcomes, researchers can develop better treatment strategies, including combination therapies and drug cycling approaches to prevent resistance from emerging.

Read More »
Scroll to Top